Abiopharma

Publication relating to transparency notifications

Preferred Bank Announces Quarterly Dividend

Steel Dynamics Provides Second Quarter 2026 Earnings Guidance

Franklin Covey to Report Third Quarter Fiscal 2026 Results

Legend Biotech Corporation Announces Proposed Public Offering

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

North Dallas Bank & Trust Co. Declares Regular Dividend

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Other Report or Announcement

Verra Mobility Announces Organizational Changes to Accelerate Transformation and Enhance Customer Focus